| Dr Ronald Jay Malloy, PHD | |
|
1138 Fremont Ave, Suite 203, South Pasadena, CA 91030 | |
| (626) 403-8389 | |
| (626) 799-0033 |
| Full Name | Dr Ronald Jay Malloy |
|---|---|
| Gender | Male |
| Speciality | Psychologist |
| Location | 1138 Fremont Ave, South Pasadena, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225139579 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | PSY5561 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ronald Jay Malloy, PHD 1138 Fremont Ave, Suite 203, South Pasadena, CA 91030 Ph: (626) 403-8389 | Dr Ronald Jay Malloy, PHD 1138 Fremont Ave, Suite 203, South Pasadena, CA 91030 Ph: (626) 403-8389 |
News Archive
A Swedish population study is helping answer lingering questions about hormone therapy safety. Published online today in Menopause, the journal of The North American Menopause Society, the study shows that estrogen-only therapy carries a lower risk of blood clots than combined estrogen-progestogen therapy, but there is no significantly increased risk of clots with combination therapy when the estrogen is transdermal, and vaginal estrogen doesn't raise the risk at all.
Cell Therapeutics, Inc. announced today that CTI received a statement on March 1, 2010 from the Gynecologic Oncology Group (GOG) leadership that the phase III GOG-212 clinical trial of CTI's OPAXIO™ used as maintenance therapy for ovarian cancer remains a high priority and enrollment will continue. The GOG made the statement to clarify that the recent results of the GOG-218 clinical trial bevacizumab in maintenance therapy for ovarian cancer has not influenced the importance of completing the GOG-212 clinical trial.
The results of a study presented today at the European League Against Rheumatism Annual Congress identify a correlation between the presence of biomarkers in the blood, known as micro RNAs (miRNAs), and the development of severe osteoarthritis (OA) of the knee or hip joint. The findings suggest that miRNAs may be used as biomarkers to predict severe OA disease in individuals.
Results indicated that one of the strongest protective factors for reducing the risk of experimenting with smoking in early adolescence was how often fathers talked with their children, both boys and girls, about 'things that mattered'.
› Verified 9 days ago
Dr. Mina Grigoryan, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1515 Hope St Ste 202, South Pasadena, CA 91030 Phone: 818-473-0970 | |
Dr. Manny Burgess, Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1910 Huntington Dr, South Pasadena, CA 91030 Phone: 626-441-6111 Fax: 626-441-6389 | |
Dr. Matthew Grant Calkins, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1515 Hope St Ste 202, South Pasadena, CA 91030 Phone: 213-595-5832 | |
Dr. Darshana U. Lele, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 719 Fremont Ave, South Pasadena, CA 91030 Phone: 626-594-5353 Fax: 888-384-0984 | |
Dr. Gabrielle Ducsay, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1015 Fremont Ave, South Pasadena, CA 91030 Phone: 424-239-9470 | |
Dr. Lisa Staab Shadburn, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 630 Mission St, Suite C2, South Pasadena, CA 91030 Phone: 626-403-3040 | |
Ms. Janet Marie Kelley, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1605 Hope Street, Suite 210, South Pasadena, CA 91030 Phone: 626-799-6771 |